Skip to main content
. Author manuscript; available in PMC: 2021 Feb 4.
Published in final edited form as: Pediatr Blood Cancer. 2016 Oct 20;64(3):10.1002/pbc.26273. doi: 10.1002/pbc.26273

FIGURE 1.

FIGURE 1

Change in procalcitonin from pre-transplant conditioning to D0 and from pre-transplant to engraftment for patients with engraftment syndrome vs. those without engraftment syndrome